| Affymax and Takeda Announce Preliminary Phase 2 Data Demonstrated That ... - Reuters |
|
|
ReutersPresentations at American Society of Nephrology Renal Week 2009 Characterize Binding, Immunogenicity Profile for Hematide PALO ALTO, Calif. ... read more |